EMG
AVIR icon

ETF Managers Group’s Atea Pharmaceuticals AVIR Stock Holding History

ETF Managers Group’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$88.6K Buy
26,460
+5,695
+27% +$23.1K ﹤0.01% 645
2022
Q4 		$99.9K Sell
20,765
-3,804
-15% -$19.2K ﹤0.01% 491
2022
Q3 		$140K Sell
24,569
-1,735
-7% -$13.3K ﹤0.01% 632
2022
Q2 		$192K Buy
26,304
+1,059
+4% +$7.23K 0.01% 646
2022
Q1 		$179K Buy
25,245
+129
+0.5% +$876 ﹤0.01% 607
2021
Q4 		$227K Sell
25,116
-5,109
-17% -$79.6K ﹤0.01% 607
2021
Q3 		$971K Buy
30,225
+5,822
+24% +$161K 0.02% 274
2021
Q2 		$596K Sell
24,403
-909
-4% -$27.3K 0.01% 453
2021
Q1 		$1.42M Sell
25,312
-13,231
-34% -$894K 0.03% 233
2020
Q4 		$1.61M Buy
+38,543
New +$1.24M 0.04% 212

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return